BioNTech
BNTX
BNTX
281 hedge funds and large institutions have $7.83B invested in BioNTech in 2021 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 72 increasing their positions, 79 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.12% more ownership
Funds ownership: 12.53% → 14.65% (+2.1%)
9% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 79
33% less call options, than puts
Call options by funds: $728M | Put options by funds: $1.08B
Holders
281
Holding in Top 10
6
Calls
$728M
Puts
$1.08B
Top Buyers
| 1 | +$666M | |
| 2 | +$354M | |
| 3 | +$200M | |
| 4 |
BlackRock
New York
|
+$165M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$150M |
Top Sellers
| 1 | -$178M | |
| 2 | -$98.3M | |
| 3 | -$69.8M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$69M |
| 5 |
Primecap Management
Pasadena,
California
|
-$58.4M |